Clinical Trial Update: Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating the efficacy of N-Acetylcysteine for overt diabetic nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: Diabetic Nephropathy, Chronic Kidney Disease | Phase 2, Phase 3 | Status: COMPLETED